Nanox to Report Second Quarter and Financial Results on August 20, 2024
Nanox to Report Second Quarter and Financial Results on August 20, 2024
PETACH TIKVA, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2024, before market open on Tuesday, August 20, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
以色列彼塔克提克瓦，2024年8月6日 /美通社/ -- 創新醫療影像技術公司納諾克斯影像有限公司(Nanox或"該公司"，納斯達克股票代碼：NNOX)今天宣佈，將於2024年8月20日星期二美國東部時間上午8:30公佈截至2024年6月30日季度業績。首席執行官暨代理主席埃雷茲·梅爾澤(Erez Meltzer)和首席財務官蘭·丹尼爾(Ran Daniel)將主持電話會議，審查這些結果並提供業務更新。
Interested parties may register for the conference call using the following link: Nanox Q2 Earnings Call Registration. You may access the live webcast of the conference call by using the following link: Nanox Q2 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. An archived replay of the webcast will also be available on the website shortly after the completion of the call.
有意參加電話會議的人士可以使用以下鏈接進行註冊：Nanox Q2 Ernings Call Registration。您可以使用以下鏈接訪問電話會議的直播網絡廣播：Nanox Q2 Ernings Webcast。該鏈接也將發佈在納諾克斯網站的投資者關係--活動和演示文稿欄目中。網路廣播的存檔回放也將在電話會議結束後不久在網站上提供。
About Nanox
關於Nanox
Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox's vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox's subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox's products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit .
納諾克斯影像有限公司(NASDAQ: NNOX)專注於應用專有的醫療影像技術和解決方案，使全球的診斷醫學更具可訪問性和可承擔性。納諾克斯的願景是提高醫學影像技術和流程的效率，以實現更早期的檢測和治療，這被認爲是有助於人們獲得更好的健康結果，並最終挽救生命的關鍵。納諾克斯的生態系統包括Nanox.ARC -- 一種多源數字斷層攝影系統，具有成本效益和用戶友好性；一套基於人工智能的算法( Nanox.AI)，可增強常規CT影像的讀數，以突出與慢性疾病常有關聯的早期跡象；雲計算基礎設施(Nanox.CLOUD);通過納諾克斯子公司USARAD Holdings Inc.提供遠程影像學和心臟病學專家的專業分散市場；以及一個綜合的遙診服務平台(Nanox.MARKETPLACE)。納諾克斯的產品和服務共同構成了一個全球創新和綜合的解決方案，連接了醫學影像解決方案，從掃描到診斷。欲了解更多信息，請訪問。
ContactsMedia Contact:Ben ShannonICR WestwickeNanoxPR@icrinc.comInvestor Contact:Mike CavanaughICR Westwickemike.cavanaugh@westwicke.com
媒體聯繫人：Ben Shannon，ICR Westwicke，NanoxPR@icrinc.com；投資者聯繫人：Mike Cavanaugh，ICR Westwicke，mike.cavanaugh@westwicke.com。
譯文內容由第三人軟體翻譯。